Search Results 171-180 of 17407 for Interferon

  1. A Study of the Safety and Effectiveness of Combined Copaxone and Estriol for Relapsing Remitting Multiple Sclerosis - Mayo Clinic

    ... interferon-gamma, and interleukin-6, with increased interleukin-5] and decreased CNS white matter inflammation and demyelination. Interestingly, decreased ...

  2. Simvastatin (oral route) - Side effects & dosage - Mayo Clinic

    Interferon Beta; Kratom; Levothyroxine; Oat Bran; Oxcarbazepine; Pectin; St John's Wort. Other Interactions. Certain medicines should not be used at or around ...

  3. Theophylline and guaifenesin (oral route) - Side effects & dosage - Mayo Clinic

    Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

  4. Temsirolimus and Bevacizumab in Treating Patients with Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer - Mayo Clinic

    Prior interferon ≥ 4 weeks prior to registration; Radiolabeled octreotide therapy (patients with prior radiolabeled octreotide therapy should have ...

  5. vasculitis Archives - Mayo Clinic News Network

    ... interferon beta compared with another inflammatory protein, type 1 interferon alpha, do not respond as well to tumor necrosis factor inhibitors as others ...

  6. Atorvastatin (oral route) - Side effects & dosage - Mayo Clinic

    Interferon Beta; Norethindrone; Oat Bran; Pectin; Pioglitazone; Quinine; Rifampin; St John's Wort; Ticagrelor. Other Interactions. Certain medicines should not ...

  7. Publications - Sarah E. Berini, M.D. - Mayo Clinic

    Publications · Rashed HR, Staff NP, Milone M, Mauermann ML, Berini S, Cheshire WP, Coon EA, Fealey RD, Sorenson E, Cutsforth-Gregory J, Benarroch EE, Sandroni P, ...

  8. Simvastatin and niacin (oral route) - Side effects & dosage - Mayo Clinic

    Interferon Beta; Levothyroxine; Oat Bran; Oxcarbazepine; Pectin; St John's Wort; Warfarin. Other Interactions. Certain medicines should not be used at or around ...

  9. Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma - Mayo Clinic

    Systemic cyclosporine, interferon; Systemic acitretin, etretinate, isotretinoin; Systemic methotrexate; Systemic photoallergic, phototoxic and/or ...

  10. A Study of Subcutaneous Nivolumab + Relatlimab FDC in Previously Untreated Metastatic or Unresectable Melanoma - Mayo Clinic

    Interferon therapy with the last dose at least 6 weeks prior to randomization. BRAF- or MEK-inhibitor-containing adjuvant therapy regimens with at least 6 ...